bevacizumab,ribociclib,lee011,177Lu-PSMA-617
roche,novartis
['pcsm', 'bcsm', 'cairo5', 'ribociclib', 'crpc', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'monaleesa2']
day 4 #asco22 highlights #communityoncology perspective 1. #cairo5: folfoxiri + bev vs. folfox/folfiri + bev in #crcsm 2. ribociclib dose reduction impact on os, #monaleesa2 3. #vision: ga-psma-pet in mcrpc #bcsm #pcsm 1/4
Practice changing #Oncology news from #CommunityOncologists perspective w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @GuthrieClinic. Views are our own.